Skip to main content
PMC home page
Springer logoLink to Springer
. 2023 Aug 19;24(6):963–964. doi: 10.1007/s40257-023-00813-4

Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

Andrea Chiricozzi 1,2,✉, Michela Ortoncelli 3, Donatella Schena 4, Niccolò Gori 1,2, Silvia Mariel Ferrucci 5, Graziella Babino 6, Maddalena Napolitano 7, Maria Concetta Fargnoli 8,9, Luca Stingeni 10, Mariateresa Rossi 11, Marco Romanelli 12, Riccardo Balestri 13, Michele Pellegrino 14, Aurora Parodi 15, Alberto Maria Bertoldi 16, Giovanni Palazzo 17, Flaminia Antonelli 1,2, Annalisa Pitino 18, Giovanni Tripepi 19, Gabriella Fabbrocini 7, Anna Balato 6, Angelo Valerio Marzano 5,20, Giampiero Girolomoni 4, Simone Ribero 3, Ketty Peris 1,2
PMCID: PMC10570227  PMID: 37597128

Correction to: American Journal of Clinical Dermatology 10.1007/s40257-023-00798-0

In the Acknowledgements section of this article the last sentence, which previously read:

“Medical writing was funded through a donation by AbbVie Srl.”

should have read:

“Medical writing was funded by SIDeMaST.”

The original article has been corrected.

Articles from American Journal of Clinical Dermatology are provided here courtesy of Springer

RESOURCES